| Identification | More |  [Name]
  4-Chloro-isatoic anhydride |  [CAS]
  40928-13-0 |  [Synonyms]
  4-CHLORO-ISATOIC ANHYDRIDE 6-CHLOROISATOIC ANHYDRIDE 7-CHLORO-1H-BENZO[D][1,3]OXAZINE-2,4-DIONE 7-CHLOROISATOIC ANHYDRIDE AURORA KA-6696 4-CHLOROISATONIC ANHYDRIDE 7-Chloro-2H-3,1-benzoxazine-2,4(1H)-dione,  7-Chloroisatoic  anhydride 7-chloro-2H-3,1-benzoxazine-2,4(1H)-dione |  [Molecular Formula]
  C8H4ClNO3 |  [MDL Number]
  MFCD00090431 |  [Molecular Weight]
  197.58 |  [MOL File]
  40928-13-0.mol |  
 | Safety Data | Back Directory |  [Hazard Codes ]
  Xn |  [Risk Statements ]
  R22:Harmful if swallowed. R36/37/38:Irritating to eyes, respiratory system and skin . |  [Safety Statements ]
  S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37:Wear suitable protective clothing and gloves . |  [WGK Germany ]
  3 |  [HazardClass ]
  IRRITANT |  [HS Code ]
  2934999090 |  
 | Hazard Information | Back Directory |  [Chemical Properties]
  White solid |  [Synthesis Reference(s)]
  The Journal of Organic Chemistry, 26, p. 613, 1961 DOI: 10.1021/jo01061a618 |  [Synthesis]
 
 General procedure for the synthesis of 7-chloro-1H-benzo[d][1,3]oxazine-2,4-dione from triphosgene and 2-amino-4-chlorobenzoic acid:
1. Preparation of Intermediate G: To a stirred solution of 2-amino-4-chlorobenzoic acid (10 g, 0.058 mol) in acetonitrile (60 mL), a solution of pyridine (9.4 mL, 0.117 mol, 2 eq.) and triphosgene (17.3 g, 0.058 mol, 1 eq.) in dichloromethane (85 mL, 0.7 M) was slowly added.
2. Treatment of the reaction mixture: the resulting orange reaction solution was heated at 50 °C for 2 h and subsequently cooled to room temperature.
3. Separation and purification: the reaction solution was diluted with water (50 mL) to separate the organic and aqueous layers. The aqueous layer was extracted with dichloromethane (3 x 50 mL) and the combined organic layers were washed once with brine (50 mL) and dried with anhydrous magnesium sulfate. 4. Purification of products: The reaction solution was heated at 50 °C for 2 h and subsequently cooled to room temperature.
4. Purification of product: The solvent was removed by distillation under reduced pressure to give a yellow solid. The solid was recrystallized from hexane to give 7-chloro-1H-benzo[d][1,3]oxazine-2,4-dione (9.1 g, 74% yield) as a yellow solid.
1H NMR (acetone-d6, 500 MHz): δ (ppm) 7.13-7.14 (1H, s), 7.28-7.30 (1H, d, J = 8.5 Hz), 7.90-7.92 (1H, d, J = 8.6 Hz), 11.84 (1H, bs).  |  [References]
  [1] Journal of Medicinal Chemistry,  2015,  vol. 58,  # 17,  p. 6928 - 6937 [2] Journal of Medicinal Chemistry,  2006,  vol. 49,  # 7,  p. 2311 - 2319 [3] Patent: US9126978,  2015,  B2. Location in patent: Page/Page column 57; 58 [4] European Journal of Medicinal Chemistry,  1994,  vol. 29,  # 12,  p. 925 - 940 [5] Bioorganic and Medicinal Chemistry Letters,  2014,  vol. 24,  # 10,  p. 2295 - 2299 |  
  
             | 
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
             |